WLS Human

Wntless Human Recombinant
Shipped with Ice Packs
In Stock

Description

Introduction

WLS (Wnt Ligand Secretion Mediator), also known as Wntless or GPR177, is a critical transmembrane protein involved in the secretion and transport of Wnt signaling proteins. Wnts are evolutionarily conserved ligands that regulate embryogenesis, tissue homeostasis, and stem cell maintenance . WLS ensures proper Wnt trafficking by binding to lipid-modified Wnts in the endoplasmic reticulum (ER) and facilitating their secretion . Dysregulation of WLS is implicated in developmental disorders, cancer, and neurological conditions .

2.1. Domain Architecture

WLS is an 8-transmembrane (TM) domain protein with both N- and C-termini on the cytosolic side. Key structural features include:

  • Luminal Domain (WLS-LD): A β-sandwich structure between TM1 and TM2, essential for Wnt binding .

  • Hydrophobic Cavity: Facilitates insertion of Wnt hairpin loops, particularly accommodating the palmitoleated Ser186 residue of Wnt8A .

  • Disulfide Bonds: Four conserved cysteines stabilize the WLS-LD .

3.1. Wnt Binding and Secretion

WLS mediates Wnt secretion through a multi-step process:

  1. Palmitoleation Dependency: Wnt binding to WLS requires PORCN-catalyzed O-palmitoleation .

  2. Conformational Switch: Wnt hairpin 2 inserts into WLS’s hydrophobic cavity, enabling palmitoleate integration into the lipid bilayer .

  3. Vesicular Release: Acidification of secretory vesicles triggers Wnt release from WLS, allowing extracellular dispersal .

3.2. Regulatory Roles

  • Feedback Control: WLS regulates Wnt protein sorting and secretion in a feedback loop .

  • Glycosylation Influence: N-glycans on Wnts (e.g., Asn103 in WNT8A) mediate interactions with WLS and co-receptors like LRP5/6 .

4.1. Cancer

  • Melanoma:

    • WLS expression is reduced in human melanoma cell lines and tumors compared to benign nevi (p<0.01p < 0.01) .

    • Knockdown of WLS enhances melanoma cell migration, proliferation, and metastasis in vivo .

WLS Expression in MelanomaSample TypeWLS-Positive (%)p-value vs. Normal
Benign Nevi9/11 (82%)-
Primary Melanoma9/18 (50%)p=0.0156p = 0.0156

4.2. Neurological and Addiction Pathways

  • Opioid Interaction: WLS binds mu-opioid receptors (MOR), modulating Wnt secretion in response to opioids .

  • Dopamine and Cannabinoid Systems: WLS interacts with dopamine transporters and cannabinoid receptors, suggesting roles in reward pathways .

5.1. Key Studies

  1. Structural Insights (2020): Cryo-EM revealed WNT8A-WLS binding mechanics, highlighting a 2403 Ų interface and conserved disulfide bonds .

  2. Melanoma Metastasis (2012): WLS loss promotes β-catenin-independent proliferation and lung metastasis in xenografts .

  3. Genetic Associations (2013): Case-control studies identified nominal associations between WLS variants and opioid/cocaine addiction, though none survived multiple testing correction .

5.2. Interaction Partners

WLS InteractorsFunctionDisease Relevance
Mu-opioid receptor (MOR)Regulates Wnt secretionOpioid addiction
Dopamine transporterModulates reward pathwaysCocaine addiction
Cannabinoid receptorsAffects lipid metabolismNeurological disorders

Therapeutic Potential

  • Cancer Therapy: Restoring WLS expression inhibits melanoma growth via β-catenin signaling .

  • Drug Development: Targeting WLS-Wnt interactions could modulate aberrant signaling in cancers and developmental disorders .

Product Specs

Introduction
WLS, also known as Wnt trafficking regulator, is a protein found within cell membranes. It plays a crucial role in ensuring the proper distribution and release of another protein called Wnt. WLS is essential for organ development during embryonic stages and the establishment of the body's head-to-tail axis. The gene encoding WLS is located on human chromosome 1 and can generate multiple protein isoforms through alternative splicing. Dysregulation of WLS is linked to the progression of certain cancers like glioma.
Description
This product consists of the human WLS protein manufactured recombinantly using E. coli bacteria. It is a single, non-glycosylated polypeptide chain comprised of 155 amino acids (specifically, positions 101 to 232a.a). The protein has a molecular weight of 17.8 kDa. For purification and detection purposes, a 23 amino acid His-tag is attached to the N-terminus of the WLS protein.
Physical Appearance
Clear and colorless solution that has been sterilized through filtration.
Formulation
The WLS protein is provided at a concentration of 1mg/ml in a solution containing 20mM Tris-HCl buffer (pH 8.0), 0.4M Urea, and 10% glycerol.
Stability
For short-term storage (2-4 weeks), the product can be stored at 4°C. For longer storage, freezing at -20°C is recommended. Adding a carrier protein (0.1% HSA or BSA) can enhance stability during long-term storage. Repeated freezing and thawing of the product should be avoided.
Purity
The purity of the WLS protein is greater than 90% as determined by SDS-PAGE analysis.
Synonyms
C1orf139, EVI, GPR177, MRP, Protein wntless homolog, Integral membrane protein GPR177, Protein evenness interrupted homolog, Putative NF-kappa-B-activating protein 373, WLS.
Source
E.coli.
Amino Acid Sequence
MGSSHHHHHH SSGLVPRGSH MGSMEMSPWF QFMLFILQLD IAFKLNNQIR ENAEVSMDVS LAYRDDAFAE WTEMAHERVP RKLKCTFTSP KTPEHEGRYY ECDVLPFMEI GSVAHKFYLL NIRLPVNEKK KINVGIGEIK DIRLVGIHQN GGFTK.

Q&A

What is the Wisconsin Longitudinal Study and what makes it methodologically unique?

The Wisconsin Longitudinal Study (WLS) represents a pioneering longitudinal research initiative tracking 10,317 individuals who graduated from Wisconsin high schools in 1957, along with selected siblings and spouses. The methodological distinctiveness of WLS stems from its exceptional temporal scope, covering more than half a century of participants' lives with multiple data collection waves (1957, 1964, 1975, 1992, 2004, and 2011) .

Unlike cross-sectional studies, WLS employs a random sampling approach (capturing 1/3 of all 1957 Wisconsin high school graduates) and maintains remarkable participant retention rates, with response rates exceeding 80% for in-person interviews in recent waves . The study's methodological evolution includes diverse data collection approaches—transitioning from initial questionnaires to telephone surveys, mail surveys, and eventually in-person assessments incorporating cognitive tests and physical measurements .

How has the WLS data collection methodology evolved over time?

The methodological framework of the WLS has demonstrated considerable adaptability across its multi-decade span, reflecting advances in research methodologies:

  • Initial phase (1957): In-person questionnaire administration to high school seniors

  • Second wave (1964): Shifted to mail survey methodology targeting parents

  • Mid-period (1975): Implemented telephone survey techniques

  • Modern period (1992-2004): Utilized hybrid methodology combining telephone and mail surveys

  • Contemporary approach (2010-2012): Returned to in-person interview protocols with expanded biomedical components including DNA sampling and physical measurements

This methodological progression reflects an increasing emphasis on biopsychosocial integration, with the 2007 introduction of biomarker collection using Oragene saliva kits representing a significant methodological advancement . The study's recent inclusion of waivers for accessing Social Security and Medicare records further demonstrates its innovative approach to data linkage across administrative and research contexts.

What are the core research domains covered by the Wisconsin Longitudinal Study?

The Wisconsin Longitudinal Study employs a comprehensive methodological framework addressing multiple interconnected research domains:

  • Life course development trajectories

  • Intergenerational transfers and relationships

  • Family functioning dynamics

  • Physical and mental health outcomes

  • Morbidity and mortality patterns

  • Educational attainment effects

  • Occupational career development

  • Social participation patterns

  • Psychological characteristic stability and change

  • Retirement transition processes

This multidimensional approach allows researchers to examine complex interactions between social determinants, personal characteristics, and health outcomes across the lifespan, making it an invaluable methodological resource for understanding human development in social context.

What methodological approaches should researchers employ when analyzing selection bias in the WLS?

When addressing selection bias in the Wisconsin Longitudinal Study, researchers must implement sophisticated methodological controls that account for both initial sampling parameters and subsequent attrition patterns. The WLS sample explicitly represents 1957 Wisconsin high school graduates, necessitating careful consideration of educational selection effects when generalizing findings .

Advanced researchers should employ:

  • Propensity score matching techniques to compare WLS participants with nationally representative datasets

  • Sensitivity analyses that model potential effects of educational non-completion

  • Inverse probability weighting to adjust for differential attrition patterns

  • Comparison of complete-case analyses with multiple imputation approaches

The extensive documentation of participant characteristics allows researchers to model selection processes explicitly rather than treating them as unmeasured confounders. Researchers should particularly note that the geographic and temporal specificity of the sample (Wisconsin, late 1950s) presents both methodological challenges and unique opportunities for understanding cohort effects .

How can researchers effectively integrate biomarker and survey data in the WLS for multidimensional analysis?

Integrating biomarker and survey data within the WLS requires sophisticated methodological approaches that account for temporal dissociation between data collection waves and potential differential participation in biomarker sampling. Researchers should implement:

  • Temporal alignment procedures that account for the specific timing of biomarker collection (2007) relative to survey waves

  • Multiple imputation techniques for handling differential participation in biomarker collection

  • Structural equation modeling approaches that explicitly incorporate measurement error in both biomarker and self-report data

  • Latent growth curve models that can accommodate mixed measurement timing

The saliva-based DNA samples collected using Oragene kits provide opportunities for gene-environment interaction studies, but researchers must carefully consider statistical power implications given the specific genetic variants examined and their population frequency . Additionally, researchers should consider employing Bayesian updating approaches when integrating the 2010-2012 physical measurements with earlier self-reported health data to model health trajectories with increasing precision.

What methodological considerations are essential when analyzing intergenerational outcomes in the WLS?

Analyzing intergenerational outcomes in the WLS presents unique methodological challenges requiring advanced analytical approaches:

  • Explicitly modeling selection into parenthood, as reproductive decisions may correlate with primary outcomes of interest

  • Implementing cross-classified multilevel models that account for nesting of children within families while allowing for complex family structures

  • Employing counterfactual approaches to distinguish direct intergenerational transmission from period and cohort effects

  • Utilizing instrumental variable techniques to address potential endogeneity in parental investment decisions

Researchers must carefully consider how the unique historical positioning of the WLS cohort (predominantly parents during the 1960s-1980s) affects the generalizability of intergenerational findings . The WLS methodology explicitly includes selected siblings, allowing for within-family designs that can partially control for shared family background, though careful attention to the non-random selection of these siblings is necessary for valid inference.

What is the WLS protein and what cellular functions does it regulate?

The Wnt Ligand Secretion Mediator (WLS) functions as an essential regulatory protein that mediates the sorting and secretion of Wnt proteins through a feedback regulatory mechanism. Structurally, WLS contains a lipid-binding domain with a β-barrel configuration resembling the lipocalin-family fold, which facilitates its interaction with lipid-modified Wnt proteins .

Functionally, WLS:

  • Binds to Wnt proteins in the endoplasmic reticulum

  • Transports these proteins through the secretory pathway

  • Facilitates their release at the cell surface

  • Recycles back to the Golgi complex through endocytosis and retromer complex recruitment

This reciprocal interaction plays a critical role in regulating the expression, subcellular localization, binding capacity, and organelle-specific association of Wnt proteins, which are fundamental signaling molecules involved in embryonic development and tissue homeostasis .

Where is the WLS protein located within human cells?

The WLS protein exhibits distinct subcellular localization patterns that reflect its functional role in Wnt protein trafficking. Research indicates that WLS is distributed across multiple cellular compartments, including:

  • Endoplasmic reticulum membrane (primary location in human cells)

  • Golgi apparatus

  • Early endosomes

  • Plasma membrane

This distribution pattern aligns with WLS's function in transporting Wnt proteins from their site of synthesis in the endoplasmic reticulum through the secretory pathway to the plasma membrane. After releasing Wnt proteins, WLS undergoes endocytosis and is recycled back to the Golgi apparatus via retromer-mediated transport, completing a trafficking circuit essential for sustained Wnt secretion .

What human diseases are associated with WLS dysfunction?

Disruptions in WLS function have been linked to specific human developmental disorders and potential contributions to disease processes:

  • Zaki Syndrome - A developmental disorder characterized by prenatal- and postnatal-onset abnormalities including brain malformations, hairlessness, and skeletal defects

  • Focal Dermal Hypoplasia - A genetic disorder affecting skin, skeletal, ocular, and dental development

  • Volkmann Contracture - A condition involving permanent contracture of muscles/tendons in the hand and forearm

These associations reflect the critical role of WLS in regulating Wnt signaling, which is fundamental to proper embryonic development, tissue homeostasis, and cellular communication. The connection between WLS dysfunction and these disorders underscores the protein's significance in human developmental processes and tissue maintenance .

How can researchers experimentally manipulate WLS to study Wnt signaling mechanisms?

Advanced investigation of WLS function requires sophisticated experimental manipulation techniques that target specific aspects of its activity:

  • Small-molecule inhibitor approach: Researchers can employ marine natural products such as chondropsins that indirectly affect WLS-Wnt interactions by inhibiting vacuolar acidification through V-ATPase blockade. This approach reveals the pH-dependency of WLS-mediated Wnt release .

  • Site-directed mutagenesis: Targeted mutation of the lipid-binding domain in WLS can disrupt interaction with palmitoylated Wnt proteins. Particular attention should be paid to residues that comprise the predicted β-barrel structure resembling the lipocalin-family fold .

  • Conditional knockout systems: Implementing tissue-specific and temporally controlled WLS deletion using Cre-loxP systems allows researchers to distinguish between developmental and homeostatic requirements for WLS function.

  • Fluorescent fusion protein tracking: Creating WLS-fluorescent protein fusions enables real-time visualization of WLS trafficking dynamics in living cells, particularly when combined with pH-sensitive fluorophores that can report on vesicular acidification states .

When designing these experiments, researchers should incorporate appropriate controls that distinguish between effects on WLS function versus indirect effects on general secretory pathway function or cell viability.

What is the significance of vacuolar acidification in WLS-mediated Wnt secretion?

The acidification of secretory vesicles represents a critical regulatory mechanism in WLS-mediated Wnt secretion with significant implications for experimental design and therapeutic targeting. Research employing V-ATPase inhibitors has revealed:

  • Inhibition of vacuolar acidification results in accumulation of the WNT3A-WLS complex both intracellularly and at the plasma membrane, indicating that acidic pH is required for complex dissociation .

  • This pH-dependent release mechanism appears specifically required for the transfer of palmitoylated WNT3A from WLS to downstream carrier proteins, potentially including lipoproteins or lipocalins .

  • The process exhibits specificity, as acidification inhibitors do not disrupt the earlier steps of Wnt glycosylation or lipidation, nor do they prevent WNT3A-WLS binding; rather, they specifically block the release phase .

These mechanistic insights suggest that vesicular acidification serves as a regulatory checkpoint in WLS-dependent Wnt secretion. The physiological relevance of this mechanism is demonstrated by the ability of V-ATPase inhibitors to affect both β-catenin-dependent and -independent Wnt signaling in vertebrate development, highlighting the conserved nature of this regulatory process .

How does the lipid modification of Wnt proteins affect their interaction with WLS?

The relationship between Wnt lipid modifications and WLS binding represents a sophisticated regulatory mechanism with significant experimental implications. Research has elucidated several critical aspects of this interaction:

  • Specific palmitoylation of WNT3A at serine residue 209 (Ser209) is required for binding to WLS, demonstrating a lipid-dependent interaction mechanism. This acylation is mediated by the Porcupine (PORCN) enzyme, making PORCN activity a prerequisite for WLS-Wnt interaction .

  • In contrast, palmitoylation at cysteine 77 (Cys77) is not required for WLS binding, indicating specificity in how different lipid modifications affect protein-protein interactions in this pathway .

  • The lipid-binding domain of WLS, predicted to adopt a β-barrel structure similar to lipocalin-family proteins, suggests a direct interaction between the protein and the Ser209 palmitate moiety of WNT3A .

  • This lipid-dependent interaction mechanism likely facilitates the transfer of hydrophobic Wnt proteins through the aqueous environment of the secretory pathway and may be critical for their subsequent association with extracellular lipoprotein particles that mediate longer-range signaling .

Experimental approaches to study this interaction should include site-directed mutagenesis of both the Ser209 acylation site in Wnt proteins and the predicted lipid-binding residues in WLS, along with biochemical assays to quantify binding affinities under various conditions of lipid modification.

How can researchers design effective field experiments to study WLS-related phenomena?

When designing field experiments to investigate WLS-related phenomena (either Wisconsin Longitudinal Study or Wnt Ligand Secretion Mediator in naturalistic settings), researchers should implement methodologically rigorous approaches that balance internal and external validity:

  • Random assignment of subjects: Distribute participants randomly across experimental conditions to ensure equal probability of assignment to different treatment groups. This randomization process is critical for establishing causal relationships in field settings .

  • Ecological validity considerations: Acknowledge that controlled laboratory experiments often lack ecological validity. Field experiments provide an opportunity to observe WLS-related outcomes in natural surroundings, though with less control over potential confounding variables .

  • Observer effect mitigation: Implement protocols to minimize Hawthorne effects, where participant behavior changes due to awareness of being observed. This is particularly relevant when studying social or behavioral outcomes in WLS participants .

  • Standardization within constraints: While maintaining naturalistic settings, standardize critical experimental parameters to enable replication by other researchers, enhancing the credibility of findings .

For Wisconsin Longitudinal Study research specifically, leveraging the existing longitudinal data structure while implementing experimental manipulations requires careful consideration of how new experimental conditions might interact with historical data collection approaches .

What methodological approaches can resolve data contradictions in WLS research?

Resolving data contradictions in WLS research requires sophisticated methodological approaches that account for the complexity of longitudinal data and potential sources of inconsistency:

  • Triangulation of multiple measures: When contradictions emerge between self-reported and objective measures (such as biomarkers in the Wisconsin Longitudinal Study), researchers should implement formal triangulation methods that explicitly model measurement error in each data source.

  • Temporal resolution analysis: For contradictions that may reflect genuine change over time rather than measurement error, researchers should employ time-series analysis techniques that can distinguish between trend, cyclical, and random components of variation.

  • Mixed-methods integration: Combining quantitative analyses with qualitative interviews from subsamples of participants can help clarify apparent contradictions by providing contextual understanding of how participants interpret questions or experience phenomena differently across time.

  • Sensitivity analysis framework: Implementing systematic sensitivity analyses that vary methodological assumptions can determine whether contradictions persist across different analytical approaches or are artifacts of specific methodological choices.

In the context of Wnt Ligand Secretion Mediator research, contradictions between in vitro and in vivo findings should be approached through systematic comparison of experimental conditions and cellular contexts, with particular attention to differences in pH regulation, lipid environments, and interaction partners that might explain divergent results .

How can data from the Wisconsin Longitudinal Study inform research on WLS protein function in aging populations?

The integration of Wisconsin Longitudinal Study data with molecular research on the Wnt Ligand Secretion Mediator represents an innovative transdisciplinary approach to understanding aging processes:

  • Biomarker-phenotype correlation analysis: The extensive biomarker collection in the WLS (including DNA samples) provides opportunities to examine how genetic variants in the WLS gene correlate with longitudinal health trajectories and age-related outcomes documented in the study .

  • Gene-environment interaction models: Researchers can leverage the detailed environmental, social, and behavioral data in the Wisconsin Longitudinal Study to investigate how these factors might modify the effects of WLS genetic variants on aging outcomes.

  • Pathway-specific analyses: Given WLS protein's involvement in Wnt signaling pathways, which influence tissue regeneration and homeostasis, researchers can examine whether biomarkers of Wnt pathway activity correlate with patterns of healthy aging or disease progression in the WLS cohort.

  • Longitudinal expression studies: For subsets of Wisconsin Longitudinal Study participants with available tissue samples, researchers could examine whether WLS expression patterns change with age and whether such changes correlate with health outcomes tracked in the longitudinal dataset.

This integrative approach requires careful attention to study design, particularly regarding the timing of sample collection relative to phenotype assessment, but offers unique opportunities to bridge molecular mechanisms with population-level aging patterns.

Product Science Overview

Discovery and Nomenclature

Wntless was initially identified through genetic studies in Drosophila and C. elegans, where it was found to be essential for the secretion of Wnt proteins . The protein is known by several names, reflecting its discovery in different organisms and contexts. In humans, it is commonly referred to as Wntless or WLS.

Structure and Function

Wntless is a multiple-pass transmembrane protein that resides in the endoplasmic reticulum (ER) and Golgi apparatus . It binds to Wnt proteins within the cell and facilitates their transport to the cell surface, where they can be secreted into the extracellular environment. This process is critical for the activation of Wnt signaling pathways in target cells.

Biological Significance

The Wnt signaling pathway is highly conserved across multicellular animals and is involved in numerous biological processes. It plays a crucial role in early embryonic development, tissue homeostasis, and stem cell renewal . Dysregulation of Wnt signaling has been implicated in various diseases, including cancer, making Wntless a protein of significant interest in biomedical research.

Recent Research

Recent studies have provided detailed insights into the structure and function of Wntless. For instance, a study published in Nature Communications reported the cryo-EM structure of human Wntless in complex with Wnt3a at a resolution of 2.2 Å . This high-resolution structure revealed three major binding regions between Wntless and Wnt3a, which are crucial for their interaction and the subsequent secretion of Wnt3a .

Therapeutic Potential

Understanding the molecular mechanisms of Wntless-mediated Wnt secretion has significant therapeutic implications. The high-resolution structure of the Wntless-Wnt3a complex provides valuable insights for the development of targeted therapies for diseases associated with aberrant Wnt signaling, such as cancer .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.